View Future GrowthOddity Tech 過去の業績過去 基準チェック /16Oddity Techは、平均年間30.8%の収益成長を遂げていますが、 Personal Products業界の収益は、年間 成長しています。収益は、平均年間13.7% 21.7%収益成長率で 成長しています。 Oddity Techの自己資本利益率は17.2%であり、純利益率は7%です。主要情報30.76%収益成長率29.67%EPS成長率Personal Products 業界の成長8.70%収益成長率21.68%株主資本利益率17.25%ネット・マージン6.97%前回の決算情報31 Mar 2026最近の業績更新お知らせ • May 15Oddity Tech Ltd. to Report Q1, 2026 Results on Jun 02, 2026Oddity Tech Ltd. announced that they will report Q1, 2026 results Pre-Market on Jun 02, 2026お知らせ • Feb 20Oddity Tech Ltd. to Report Q4, 2025 Results on Feb 25, 2026Oddity Tech Ltd. announced that they will report Q4, 2025 results Pre-Market on Feb 25, 2026お知らせ • Oct 23Oddity Tech Ltd. to Report Q3, 2025 Results on Nov 20, 2025Oddity Tech Ltd. announced that they will report Q3, 2025 results After-Market on Nov 20, 2025お知らせ • Jul 24Oddity Tech Ltd. to Report Q2, 2025 Results on Aug 04, 2025Oddity Tech Ltd. announced that they will report Q2, 2025 results After-Market on Aug 04, 2025すべての更新を表示Recent updatesお知らせ • Jun 17Oddity Tech Ltd., Annual General Meeting, Jul 29, 2026Oddity Tech Ltd., Annual General Meeting, Jul 29, 2026. Location: herzog, fox & neeman, 6 yitzhak sadeh st., 6777506., tel aviv-jaffa IsraelValuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 15%After last week's 15% share price gain to €9.58, the stock trades at a trailing P/E ratio of 12.9x. Average forward P/E is 17x in the Personal Products industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €9.59 per share.お知らせ • Jun 02Oddity Tech Ltd. Provides Earnings Guidance for Second Quarter of 2026Oddity Tech Ltd. provided earnings guidance for second quarter of 2026. For the quarter, the company expects net revenue to decline between 25% and 30% year-over-year.お知らせ • May 15Oddity Tech Ltd. to Report Q1, 2026 Results on Jun 02, 2026Oddity Tech Ltd. announced that they will report Q1, 2026 results Pre-Market on Jun 02, 2026お知らせ • Mar 13Pomerantz Law Firm Announces Filing of Class Action Against Oddity Tech Ltd. and Certain OfficersPomerantz LLP announced that a class action lawsuit had been filed against Oddity Tech Ltd. and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-02046, was on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Oddity securities between February 26, 2025 and February 24, 2026, both dates inclusive, seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials. The Complaint alleged that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) due to an algorithm change by Oddity's largest advertising partner, Oddity's advertisements were being diverted to lower quality auctions at abnormally high costs; (ii) the foregoing significantly increased Oddity's customer acquisition costs, thereby negatively impacting Oddity's business and financial prospects; (iii) accordingly, Defendants overstated the overall strength, stability, and sustainability of Oddity's digital operating model and/or market position; and (iv) as a result, Defendants' public statements were materially false and misleading at all relevant times. The truth began to emerge on February 25, 2026, when Oddity issued a press release announcing its financial results for the Fourth Quarter and full year ended December 31, 2025. Oddity stated that it experienced a dislocation in its account with its largest advertising partner that was believed to be driven by algorithm changes which diverted Oddity to lower quality auctions at abnormally high costs, which resulted in significant increases in new user acquisition costs that were not correlated with the market or Oddity's historical experience. Oddity's Global Chief Financial Officer stated that given the dislocation Oddity was experiencing in acquisition costs, Oddity expected First Quarter 2026 revenue to decline approximately 30% year-over-year, but hoped to see material improvement in the second half of 2026. Oddity planned to issue its financial outlook for Fiscal Year 2026 in the next few months when it had more visibility. On this news, Oddity's Class A ordinary share price fell $14.28 per share, or 49.21%, to close at $14.74 per share on February 25, 2026.お知らせ • Mar 12Oddity Tech Ltd. (NasdaqGM:ODD) announces an Equity Buyback for $200 million worth of its shares.Oddity Tech Ltd. (NasdaqGM:ODD) announces a share repurchase program. Under the program, the company will repurchase up to $200 million worth of its Class A shares. The program will expire on March 31, 2029 or once the allocated funds have been fully deployed, subject to any future modifications by the Board.お知らせ • Feb 25Oddity Tech Ltd. Provides Earnings Guidance for the First Quarter 2026Oddity Tech Ltd. provided earnings guidance for the first quarter 2026. The company is experiencing in acquisition costs, company expected first quarter 2026 revenue to decline approximately 30% year-over-year, but hope to see material improvement in the second half of 2026.お知らせ • Feb 20Oddity Tech Ltd. to Report Q4, 2025 Results on Feb 25, 2026Oddity Tech Ltd. announced that they will report Q4, 2025 results Pre-Market on Feb 25, 2026お知らせ • Nov 20+ 1 more updateOddity Tech Ltd. Provides Earnings Guidance for the Fourth Quarter Ending December 31, 2025Oddity Tech Ltd. provided earnings guidance for the Fourth quarter ending December 31, 2025. For the year ending, company expected Net revenue between $149 million and $152 million, representing year-over-year growth between 21% and 23%.お知らせ • Nov 19ODDITY Tech Ltd Launches METHODIQ, a Telehealth Platform Reimagining Medical CareODDITY Tech Ltd. announced the launch of METHODIQ, a medical telehealth platform delivering customized, high-efficacy treatments powered by online diagnosis - without needing to go to a doctor's office or get lost in a drug store. METHODIQ reimagines medical care with science, world-class treatments and AI analysis to deliver the highest standards of care - accessible to everyone. The platform begins with dermatology treatments for acne, hyperpigmentation and eczema, with plans to expand into additional medical domains. Backed by four years of investment and product testing, METHODIQ is launching with one of the most advanced and validated dermatological portfolios in the industry based on large scale consumer studies. It features 28 core products and more than 100 personalized treatment plans, engineered with the goal of unrivaled efficacy with fewer side effects and a best-in-class product experience.お知らせ • Oct 23Oddity Tech Ltd. to Report Q3, 2025 Results on Nov 20, 2025Oddity Tech Ltd. announced that they will report Q3, 2025 results After-Market on Nov 20, 2025お知らせ • Oct 01Oddity Tech Ltd., Annual General Meeting, Nov 13, 2025Oddity Tech Ltd., Annual General Meeting, Nov 13, 2025. Location: herzog, fox & neeman, 6 yitzhak sadeh st.,6777506., tel aviv-jaffa Israelお知らせ • Aug 05+ 1 more updateOddity Tech Ltd. Provides Earnings Guidance for the Third Quarter Ending September 30, 2025Oddity Tech Ltd. provided earnings guidance for the third quarter ending September 30, 2025. For the quarter, the company expects net revenue of $144 million to $146 million.お知らせ • Jul 24Oddity Tech Ltd. to Report Q2, 2025 Results on Aug 04, 2025Oddity Tech Ltd. announced that they will report Q2, 2025 results After-Market on Aug 04, 2025収支内訳Oddity Tech の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史DB:KW7 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費31 Mar 2674052475031 Dec 25810111470030 Sep 25781110450030 Jun 25752110425031 Mar 25703106394031 Dec 24647101353030 Sep 24621101311030 Jun 2459687307031 Mar 2455572291031 Dec 2350959284030 Sep 2347953247030 Jun 2345352230031 Mar 2340038199031 Dec 2232522178031 Dec 2122314134031 Dec 2011112610質の高い収益: KW7 非現金収入 のレベルが高いです。利益率の向上: KW7の現在の純利益率 (7%)は、昨年(15.1%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: KW7の収益は過去 5 年間で年間30.8%増加しました。成長の加速: KW7は過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: KW7は過去 1 年間で収益成長率がマイナス ( -51.5% ) となったため、 Personal Products業界平均 ( 2.8% ) と比較することが困難です。株主資本利益率高いROE: KW7の 自己資本利益率 ( 17.2% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YHousehold 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/24 08:58終値2026/06/24 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Oddity Tech Ltd. 10 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。11 アナリスト機関Lauren LiebermanBarclaysAnna LizzulBofA Global ResearchAndrew BooneCitizens JMP Securities, LLC8 その他のアナリストを表示
お知らせ • May 15Oddity Tech Ltd. to Report Q1, 2026 Results on Jun 02, 2026Oddity Tech Ltd. announced that they will report Q1, 2026 results Pre-Market on Jun 02, 2026
お知らせ • Feb 20Oddity Tech Ltd. to Report Q4, 2025 Results on Feb 25, 2026Oddity Tech Ltd. announced that they will report Q4, 2025 results Pre-Market on Feb 25, 2026
お知らせ • Oct 23Oddity Tech Ltd. to Report Q3, 2025 Results on Nov 20, 2025Oddity Tech Ltd. announced that they will report Q3, 2025 results After-Market on Nov 20, 2025
お知らせ • Jul 24Oddity Tech Ltd. to Report Q2, 2025 Results on Aug 04, 2025Oddity Tech Ltd. announced that they will report Q2, 2025 results After-Market on Aug 04, 2025
お知らせ • Jun 17Oddity Tech Ltd., Annual General Meeting, Jul 29, 2026Oddity Tech Ltd., Annual General Meeting, Jul 29, 2026. Location: herzog, fox & neeman, 6 yitzhak sadeh st., 6777506., tel aviv-jaffa Israel
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment improves as stock rises 15%After last week's 15% share price gain to €9.58, the stock trades at a trailing P/E ratio of 12.9x. Average forward P/E is 17x in the Personal Products industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €9.59 per share.
お知らせ • Jun 02Oddity Tech Ltd. Provides Earnings Guidance for Second Quarter of 2026Oddity Tech Ltd. provided earnings guidance for second quarter of 2026. For the quarter, the company expects net revenue to decline between 25% and 30% year-over-year.
お知らせ • May 15Oddity Tech Ltd. to Report Q1, 2026 Results on Jun 02, 2026Oddity Tech Ltd. announced that they will report Q1, 2026 results Pre-Market on Jun 02, 2026
お知らせ • Mar 13Pomerantz Law Firm Announces Filing of Class Action Against Oddity Tech Ltd. and Certain OfficersPomerantz LLP announced that a class action lawsuit had been filed against Oddity Tech Ltd. and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-02046, was on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Oddity securities between February 26, 2025 and February 24, 2026, both dates inclusive, seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials. The Complaint alleged that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) due to an algorithm change by Oddity's largest advertising partner, Oddity's advertisements were being diverted to lower quality auctions at abnormally high costs; (ii) the foregoing significantly increased Oddity's customer acquisition costs, thereby negatively impacting Oddity's business and financial prospects; (iii) accordingly, Defendants overstated the overall strength, stability, and sustainability of Oddity's digital operating model and/or market position; and (iv) as a result, Defendants' public statements were materially false and misleading at all relevant times. The truth began to emerge on February 25, 2026, when Oddity issued a press release announcing its financial results for the Fourth Quarter and full year ended December 31, 2025. Oddity stated that it experienced a dislocation in its account with its largest advertising partner that was believed to be driven by algorithm changes which diverted Oddity to lower quality auctions at abnormally high costs, which resulted in significant increases in new user acquisition costs that were not correlated with the market or Oddity's historical experience. Oddity's Global Chief Financial Officer stated that given the dislocation Oddity was experiencing in acquisition costs, Oddity expected First Quarter 2026 revenue to decline approximately 30% year-over-year, but hoped to see material improvement in the second half of 2026. Oddity planned to issue its financial outlook for Fiscal Year 2026 in the next few months when it had more visibility. On this news, Oddity's Class A ordinary share price fell $14.28 per share, or 49.21%, to close at $14.74 per share on February 25, 2026.
お知らせ • Mar 12Oddity Tech Ltd. (NasdaqGM:ODD) announces an Equity Buyback for $200 million worth of its shares.Oddity Tech Ltd. (NasdaqGM:ODD) announces a share repurchase program. Under the program, the company will repurchase up to $200 million worth of its Class A shares. The program will expire on March 31, 2029 or once the allocated funds have been fully deployed, subject to any future modifications by the Board.
お知らせ • Feb 25Oddity Tech Ltd. Provides Earnings Guidance for the First Quarter 2026Oddity Tech Ltd. provided earnings guidance for the first quarter 2026. The company is experiencing in acquisition costs, company expected first quarter 2026 revenue to decline approximately 30% year-over-year, but hope to see material improvement in the second half of 2026.
お知らせ • Feb 20Oddity Tech Ltd. to Report Q4, 2025 Results on Feb 25, 2026Oddity Tech Ltd. announced that they will report Q4, 2025 results Pre-Market on Feb 25, 2026
お知らせ • Nov 20+ 1 more updateOddity Tech Ltd. Provides Earnings Guidance for the Fourth Quarter Ending December 31, 2025Oddity Tech Ltd. provided earnings guidance for the Fourth quarter ending December 31, 2025. For the year ending, company expected Net revenue between $149 million and $152 million, representing year-over-year growth between 21% and 23%.
お知らせ • Nov 19ODDITY Tech Ltd Launches METHODIQ, a Telehealth Platform Reimagining Medical CareODDITY Tech Ltd. announced the launch of METHODIQ, a medical telehealth platform delivering customized, high-efficacy treatments powered by online diagnosis - without needing to go to a doctor's office or get lost in a drug store. METHODIQ reimagines medical care with science, world-class treatments and AI analysis to deliver the highest standards of care - accessible to everyone. The platform begins with dermatology treatments for acne, hyperpigmentation and eczema, with plans to expand into additional medical domains. Backed by four years of investment and product testing, METHODIQ is launching with one of the most advanced and validated dermatological portfolios in the industry based on large scale consumer studies. It features 28 core products and more than 100 personalized treatment plans, engineered with the goal of unrivaled efficacy with fewer side effects and a best-in-class product experience.
お知らせ • Oct 23Oddity Tech Ltd. to Report Q3, 2025 Results on Nov 20, 2025Oddity Tech Ltd. announced that they will report Q3, 2025 results After-Market on Nov 20, 2025
お知らせ • Oct 01Oddity Tech Ltd., Annual General Meeting, Nov 13, 2025Oddity Tech Ltd., Annual General Meeting, Nov 13, 2025. Location: herzog, fox & neeman, 6 yitzhak sadeh st.,6777506., tel aviv-jaffa Israel
お知らせ • Aug 05+ 1 more updateOddity Tech Ltd. Provides Earnings Guidance for the Third Quarter Ending September 30, 2025Oddity Tech Ltd. provided earnings guidance for the third quarter ending September 30, 2025. For the quarter, the company expects net revenue of $144 million to $146 million.
お知らせ • Jul 24Oddity Tech Ltd. to Report Q2, 2025 Results on Aug 04, 2025Oddity Tech Ltd. announced that they will report Q2, 2025 results After-Market on Aug 04, 2025